Hims & Hers Health, INC Form 4 insider transactions

Irene Becklund, PAO of Hims & Hers Health, reports the sale of 2,203 shares of Class A Common Stock and the acquisition of 22,284 Restricted Stock Units.

Director Christiane Pendarvis sold 12,500 shares of Hims & Hers Health, Inc. Class A Common Stock at $40 per share on March 5, 2025.

Chief Financial Officer Oluyemi Okupe of Hims & Hers Health, Inc. exercised stock options to acquire 2,530 shares of Class A Common Stock at $5.01 per share on March 5, 2025.

Irene Becklund, PAO of Hims & Hers Health, sold 2,913 shares of Class A Common Stock at $45.14 per share on March 3, 2025, under a pre-arranged 10b5-1 trading plan.

Patrick Harrison Carroll, Chief Medical Officer and Director at Hims & Hers Health, Inc., acquired 56,529 Restricted Stock Units (RSUs) on March 3, 2025, which will vest over a four-year period.

Chief Financial Officer of Hims & Hers Health, Oluyemi Okupe, reports the acquisition of 183,719 Restricted Stock Units (RSUs) tied to Class A Common Stock, vesting quarterly over four years.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, Inc., acquired 197,851 restricted stock units (RSUs) on March 3, 2025, which will vest over a four-year period.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., acquired 169,587 Restricted Stock Units (RSUs) on March 3, 2025, which will vest over a four-year period.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., was granted 98,925 Restricted Stock Units (RSUs) on March 3, 2025, according to a Form 4 filing with the SEC.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., executed stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health CEO Andrew Dudum reports multiple transactions involving Class A Common Stock, including option exercises and sales, executed under a pre-arranged Rule 10b5-1 trading plan.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., sold 4,152 shares of Class A Common Stock at a price of $60.69 on February 18, 2025.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., executed stock options and sold shares of Class A Common Stock according to a pre-arranged Rule 10b5-1 trading plan.

Melissa Baird, Chief Operating Officer of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on February 12, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., executed stock options and sold shares of Class A Common Stock on February 10, 2025, according to a Form 4 filing with the SEC.

Hims & Hers Health CFO Oluyemi Okupe executed stock option exercises and sales of Class A Common Stock on February 10, 2025, according to a Form 4 filing.

Oluyemi Okupe, CFO of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on February 4, 2025, under a pre-arranged Rule 10b5-1 trading plan.

CEO Andrew Dudum reports the vesting and disposal of Restricted Stock Units (RSUs) and the acquisition of Class A Common Stock due to the achievement of a performance threshold.

Andrew Dudum, CEO of Hims & Hers Health, exercised stock options and sold 100,000 shares of Class A Common Stock on January 31, 2025, according to a Form 4 filing with the SEC.

Soleil Boughton, Chief Legal Officer of Hims & Hers Health, Inc., reported the sale of 4,153 shares of Class A Common Stock on February 3, 2025, at a price of $35.3 per share.

Chief Commercial Officer Michael Chi of Hims & Hers Health, Inc. executed stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, executed a stock option exercise and subsequent sale of 17,304 Class A Common shares on January 24, 2025.

Hims & Hers CEO Andrew Dudum exercised stock options and sold shares on January 23, 2025, according to a recent SEC filing.

Boughton Soleil, Chief Legal Officer of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on January 21, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health's Chief Operating Officer, Melissa Baird, exercised stock options and sold shares of Class A Common Stock on January 21, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., executed stock option exercises and sales under a pre-arranged Rule 10b5-1 trading plan.

Hims & Hers Health CEO Andrew Dudum exercised stock options and sold shares of Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.

CEO Andrew Dudum exercised stock options of Hims & Hers Health, Inc. under a pre-arranged 10b5-1 trading plan.

Hims & Hers CEO Andrew Dudum exercised stock options and sold a portion of his holdings in Class A Common Stock on January 16, 2025, under a pre-arranged 10b5-1 trading plan.

Chief Financial Officer Oluyemi Okupe of Hims & Hers Health, Inc. reports exercising stock options and selling Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.